Economic Innovation Group Applauds the Signing of the 21st Century Cures Act

Back to all news

Washington, D.C. – The Economic Innovation Group (EIG) praised the 21st Century Cures Act, which was signed into law today by President Barack Obama. This bipartisan legislation will significantly increase funding for scientific and medical research, and strengthen the process of translating scientific innovations into life-saving treatments for patients.

“I applaud President Obama’s signing of the 21st Century Cures Act into law today.  The innovation this bill encourages is needed across our government to fuel American progress,” said EIG co-founder and executive director, Steve Glickman. “The Cures Act represents an investment in innovation that will lead to healthier lives, longer lifespans and a more prosperous America.”

The 21st Century Cures Act, which was approved by Congress with large bipartisan majorities, was lauded by EIG founder and chairman, Sean Parker, whose Parker Foundation has a strong focus on life sciences and innovative treatment approaches.

“This landmark legislation will foster a stronger ecosystem for life sciences and biomedical innovation to address challenges that touch nearly every American life,” said EIG co-founder and senior director for policy and strategy, John Lettieri. “The bipartisanship and inclusive spirit that led to the passage of Cures represents the best in policymaking.”

About the Economic Innovation Group (EIG)

The Economic Innovation Group (EIG) is an ideas laboratory and advocacy organization whose mission is to advance solutions that empower entrepreneurs and investors to forge a more dynamic American economy. Headquartered in Washington, D.C. and led by an experienced, bipartisan team, EIG convenes leading experts from the public and private sectors, develops original policy research, and works to advance creative legislative proposals that will bring new jobs, investment, and economic growth to communities across the nation. For more information, visit eig.org.  

 

Media contact:

Amanda Byrd

202-839-3709

[email protected]

Your browser is out-of-date!

Update your browser to view this website correctly. Update my browser now

×